Actinium Ac 225 lintuzumab

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A radioimmunoconjugate consisting of the humanized monoclonal antibody lintuzumab conjugated to the alpha-emitting radioisotope actinium Ac 225 with potential antineoplastic activity. The monoclonal antibody moiety of actinium Ac 225 lintuzumab specifically binds to the cell surface antigen CD33 antigen, delivering a cytotoxic dose of alpha radiation to cells expressing CD33. CD33 is a cell surface antigen expressed on normal non-pluripotent hematopoietic stem cells and overexpressed on myeloid leukemia cells.

Learn more about Actinium Ac 225 lintuzumab

Latest research - Actinium Ac 225 lintuzumab

PubMed
Clinical trials

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article Actinium Ac 225 lintuzumab is a stub. If you are familiar with the topic Actinium Ac 225 lintuzumab, you can help us. Paid editors welcome!

 

Actinium Ac 225 lintuzumab is part of WikiMD's free ^articles!

^Actinium Ac 225 lintuzumab (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available